Humana reported GAAP diluted earnings per share of $1.62 and Adjusted (non-GAAP) EPS of $3.24 for Q3 2025 (3Q25). For Q3 2024 (3Q24), GAAP EPS was $3.98 and Adjusted EPS was $4.16.

1. 01

   Humana reported GAAP diluted earnings per share of $1.62 and Adjusted (non-GAAP) EPS of $3.24 for Q3 2025 (3Q25). For Q3 2024 (3Q24), GAAP EPS was $3.98 and Adjusted EPS was $4.16.

2. 02

   The company said its Insurance segment benefit ratio for Q3 2025 was 91.1%, in line with its previously disclosed expectation of 'just above 91%'. For Q3 2024, the GAAP benefit ratio was 90.6%.

3. 03

   The company said it changed its full-year 2025 GAAP EPS outlook to 'approximately $12.26' from 'approximately $13.77', and affirmed its Adjusted EPS outlook of 'approximately $17.00'.

4. 04

   Humana updated its 2025 outlook for the decline in individual Medicare Advantage membership to 'approximately 425,000 members' from 'up to 500,000 members'. The company cited stronger retention and better-than-expected sales as the factors.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.